Table of Contents
1 Study Coverage
1.1 Liver Cirrhosis Therapeutics Drugs Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Liver Cirrhosis Therapeutics Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Liver Cirrhosis Therapeutics Drugs Market Size
2.1.1 Global Liver Cirrhosis Therapeutics Drugs Revenue 2014-2025
2.1.2 Global Liver Cirrhosis Therapeutics Drugs Sales 2014-2025
2.2 Liver Cirrhosis Therapeutics Drugs Growth Rate by Regions
2.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales by Regions
2.2.2 Global Liver Cirrhosis Therapeutics Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Liver Cirrhosis Therapeutics Drugs Sales by Manufacturers
3.1.1 Liver Cirrhosis Therapeutics Drugs Sales by Manufacturers
3.1.2 Liver Cirrhosis Therapeutics Drugs Sales Market Share by Manufacturers
3.2 Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers
3.2.1 Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Liver Cirrhosis Therapeutics Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Liver Cirrhosis Therapeutics Drugs Price by Manufacturers
3.4 Liver Cirrhosis Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Liver Cirrhosis Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liver Cirrhosis Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Liver Cirrhosis Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Liver Cirrhosis Therapeutics Drugs Sales by Type
4.2 Global Liver Cirrhosis Therapeutics Drugs Revenue by Type
4.3 Liver Cirrhosis Therapeutics Drugs Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Liver Cirrhosis Therapeutics Drugs Breakdown Data by Application
6 North America
6.1 North America Liver Cirrhosis Therapeutics Drugs by Country
6.1.1 North America Liver Cirrhosis Therapeutics Drugs Sales by Country
6.1.2 North America Liver Cirrhosis Therapeutics Drugs Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Liver Cirrhosis Therapeutics Drugs by Type
6.3 North America Liver Cirrhosis Therapeutics Drugs by Application
7 Europe
7.1 Europe Liver Cirrhosis Therapeutics Drugs by Country
7.1.1 Europe Liver Cirrhosis Therapeutics Drugs Sales by Country
7.1.2 Europe Liver Cirrhosis Therapeutics Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Liver Cirrhosis Therapeutics Drugs by Type
7.3 Europe Liver Cirrhosis Therapeutics Drugs by Application
8 Asia Pacific
8.1 Asia Pacific Liver Cirrhosis Therapeutics Drugs by Region
8.1.1 Asia Pacific Liver Cirrhosis Therapeutics Drugs Sales by Region
8.1.2 Asia Pacific Liver Cirrhosis Therapeutics Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Liver Cirrhosis Therapeutics Drugs by Type
8.3 Asia Pacific Liver Cirrhosis Therapeutics Drugs by Application
9 Central & South America
9.1 Central & South America Liver Cirrhosis Therapeutics Drugs by Country
9.1.1 Central & South America Liver Cirrhosis Therapeutics Drugs Sales by Country
9.1.2 Central & South America Liver Cirrhosis Therapeutics Drugs Revenue by Country
9.1.3 Brazil
9.2 Central & South America Liver Cirrhosis Therapeutics Drugs by Type
9.3 Central & South America Liver Cirrhosis Therapeutics Drugs by Application
10 Middle East and Africa
10.1 Middle East and Africa Liver Cirrhosis Therapeutics Drugs by Country
10.1.1 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales by Country
10.1.2 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Liver Cirrhosis Therapeutics Drugs by Type
10.3 Middle East and Africa Liver Cirrhosis Therapeutics Drugs by Application
11 Company Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Company Business Overview
11.1.3 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Products Offered
11.1.5 Gilead Sciences Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Company Business Overview
11.3.3 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Business Overview
11.4.3 Merck Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Liver Cirrhosis Therapeutics Drugs Products Offered
11.4.5 Merck Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Company Business Overview
11.5.3 Roche Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Roche Liver Cirrhosis Therapeutics Drugs Products Offered
11.5.5 Roche Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Company Business Overview
11.6.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Conatus Pharmaceuticals
11.7.1 Conatus Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Products Offered
11.7.5 Conatus Pharmaceuticals Recent Development
11.8 Gwo Xi Stem Cell Applied Technology
11.8.1 Gwo Xi Stem Cell Applied Technology Company Details
11.8.2 Company Business Overview
11.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Products Offered
11.8.5 Gwo Xi Stem Cell Applied Technology Recent Development
11.9 Instituto Grifols
11.9.1 Instituto Grifols Company Details
11.9.2 Company Business Overview
11.9.3 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Products Offered
11.9.5 Instituto Grifols Recent Development
11.10 Intercept Pharmaceuticals
11.10.1 Intercept Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Products Offered
11.10.5 Intercept Pharmaceuticals Recent Development
11.11 NGM Biopharmaceuticals
11.12 Norgine
11.13 Pharmicell
11.14 Salix Pharmaceuticals
11.15 Stempeutics Research
12 Future Forecast
12.1 Liver Cirrhosis Therapeutics Drugs Market Forecast by Regions
12.1.1 Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Regions 2019-2025
12.2 Liver Cirrhosis Therapeutics Drugs Market Forecast by Type
12.2.1 Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Type 2019-2025
12.2.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Forecast by Type 2019-2025
12.3 Liver Cirrhosis Therapeutics Drugs Market Forecast by Application
12.4 North America Liver Cirrhosis Therapeutics Drugs Forecast
12.5 Europe Liver Cirrhosis Therapeutics Drugs Forecast
12.6 Asia Pacific Liver Cirrhosis Therapeutics Drugs Forecast
12.7 Central & South America Liver Cirrhosis Therapeutics Drugs Forecast
12.8 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Liver Cirrhosis Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Gilead Sciences、GlaxoSmithKline、Johnson & Johnson、Merck、Roche、Bristol-Myers Squibb、Conatus Pharmaceuticals、Gwo Xi Stem Cell Applied Technology、Instituto Grifols、Intercept Pharmaceuticals、NGM Biopharmaceuticals、Norgine、Pharmicell、Salix Pharmaceuticals、Stempeutics Research
【免責事項】
https://www.globalresearch.jp/disclaimer